Select Transactions:
Siegfried AG sells 100% of Siegfried Biologics (Germany) to Avestha Biotherapeutics and Research in India.
ICFG Zurich acted as exclusive advisor to the selller in 2007.
Siegfried AG sells 100% of Siegfried Biologics (Germany) to Avestha Biotherapeutics and Research in India.
Target Company Name Siegfried Biologics GmbH
Deal Types
  • Mergers & Acquisitions
Target Country Germany
Buyer Name / MBO Team / MBI Team Avestha Biotherapeutics and Research Pvt. Ltd.
Buyer Country India
Transaction Description

Siegfried AG (Zofingen, Switzerland), a publicly quoted chemical / pharmaceutical company (SWX: SFZN) sells 100% of Siegfried Biologics GmbH (Berlin, Germany), to Avestha Biotherapeutics and Research Pvt. Ltd. (Bangalore, India), a leading Indian biotech development company.

Vaccani, Zweig & Associates acted as exclusive M&A advisors to Siegfried AG in all phases of the sales process.

Industry Sectors
  • Healthcare, Pharmaceuticals and Medical Equipment
ICFG Office Zurich: A. Vaccani & Partners, Switzerland
ICFG Advisory ICFG Zurich acted as exclusive advisor to the selller in 2007.

< Back

© 2017 International Corporate Finance Group.   All rights reserved.

International Corporate Finance Group (ICFG) is a non-profit making association, originally established in Zurich/Switzerland, under Article 60 and following of the Swiss Civil Code.

ICFG is domiciled in PO Box 1070, 1211 Geneva 26, Switzerland.